SKYTROFA® for Adults with
Growth Hormone Deficiency (GHD)
NOW FDA APPROVED
SKYTROFA is indicated for the replacement of endogenous growth hormone in adults with growth hormone deficiency (GHD).
Sign up for updates
Sign up for the latest product news and resources.
Start a Patient
Download form for easy enrollment in the Ascendis Signature Access Program® (A·S·A·P)
Foresight Clinical Overview
Learn more about the Phase 3 trial.
SKYTROFA Adult
Product Overview
Learn more about the expanded indication.